Literature DB >> 16608618

Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women.

Vicky Drapeau1, Isabelle Lemieux, Denis Richard, Jean Bergeron, Angelo Tremblay, Simon Biron, Picard Marceau, Pascale Mauriège.   

Abstract

BACKGROUND: Obesity is well known to be associated with an increased prevalence of metabolic complications. Severe obesity is thus expected to have more important alterations of the metabolic profile than moderate obesity. This study aimed to compare the metabolic profile of pre- and postmenopausal severely obese women with moderately obese women.
METHODS: First, the metabolic profile of pre- (n=165) and postmenopausal (n=43) severely obese women (body mass index (BMI) > or =40 kg/m(2)) was compared to that of pre- (n=52) and postmenopausal (n=35) moderately obese women (BMI of 30-40 kg/m(2)). Thereafter, pre- and postmenopausal severely obese women were divided into two subgroups according to the presence/absence of a dysmetabolic profile. We used for comparison, a group of pre- and postmenopausal moderately obese women without a dysmetabolic profile.
RESULTS: The metabolic profile of pre- and postmenopausal severely obese women was less deteriorated than expected when compared to moderately obese women. Moreover, severely obese women with or without a dysmetabolic profile displayed comparable or even lower plasma levels of cholesterol, HDL and LDL-cholesterol, and a lower cholesterol/HDL-cholesterol ratio than moderately obese women (P< or =0.05). After menopause, the metabolic profile of severely obese women, dysmetabolic or not, was similar to that of moderately obese women. Blood pressure was, however, higher in severely obese women compared to moderately obese women, only before menopause (P< or =0.0001).
CONCLUSION: These results indicate that despite their large accumulation of adipose tissue, most of the severely obese women had a metabolic profile less deteriorated than expected, when compared to moderately obese women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16608618     DOI: 10.1381/096089206776327215

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  12 in total

1.  Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity.

Authors:  Stefanie R van Mil; L Ulas Biter; Gert-Jan M van de Geijn; Erwin Birnie; Martin Dunkelgrun; Jan N M IJzermans; Noelle van der Meulen; Guido H H Mannaerts; Manuel Castro Cabezas
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

2.  Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese.

Authors:  Lior Shamai; Einar Lurix; Michael Shen; Gian M Novaro; Samuel Szomstein; Raul Rosenthal; Adrian V Hernandez; Craig R Asher
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

3.  Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Authors:  Christian Carpéné; Francisco Les; Mounia Hasnaoui; Simon Biron; Picard Marceau; Denis Richard; Jean Galitzky; Denis R Joanisse; Pascale Mauriège
Journal:  J Physiol Biochem       Date:  2016-10-21       Impact factor: 4.158

4.  Pro-inflammatory phospholipid arachidonic acid/eicosapentaenoic acid ratio of dysmetabolic severely obese women.

Authors:  S Caspar-Bauguil; A Fioroni; A Galinier; S Allenbach; M C Pujol; R Salvayre; A Cartier; I Lemieux; D Richard; S Biron; P Marceau; L Casteilla; L Pénicaud; P Mauriège
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 5.  Impact of obesity and bariatric surgery on metabolism and coronary circulatory function.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Freimut D Jüngling; Giuseppe Ambrosio; Richard Wahl; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

Review 6.  Abdominal obesity: the cholesterol of the 21st century?

Authors:  Jean-Pierre Després; Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

7.  Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women.

Authors:  Vicky Drapeau; Isabelle Lemieux; Denis Richard; Jean Bergeron; Angelo Tremblay; Simon Biron; Picard Marceau; Pascale Mauriège
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

8.  Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile.

Authors:  P Mauriège; D R Joanisse; S CasparBauguil; A Cartier; I Lemieux; J Bergeron; S Biron; P Marceau; D Richard
Journal:  J Physiol Biochem       Date:  2015-10-10       Impact factor: 4.158

9.  Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.

Authors:  C Di Somma; R Pivonello; G Pizza; A De Rosa; G Lombardi; A Colao; S Savastano
Journal:  J Endocrinol Invest       Date:  2009-09-30       Impact factor: 4.256

10.  Discrepancies Between BMI and Classic Cardiovascular Risk Factors.

Authors:  Stefanie R van Mil; Guy H E J Vijgen; Astrid van Huisstede; Boudewijn Klop; Gert-Jan M van de Geijn; Erwin Birnie; Gert-Jan Braunstahl; Guido H H Mannaerts; L Ulas Biter; Manuel Castro Cabezas
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.